Skip to content
ProvidersDesk
Q5160

Inj, jobevne, 10 mg

✓ CURRENT — JULY 2026
Source: CMS
Imported: Aug 10 2026

Full descriptor

Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg

Details

Code
Q5160
Short descriptor
Inj, jobevne, 10 mg
Code set
HCPCS Level II
Release
July 2026
Status
Active
Added
Jan 1 2026

Nearby codes

Code sets are published in blocks, so neighbours are usually related.

Q5159

Inj, denosumab-dssb, 1 mg

Q5161

Inj, denosumab-kyqq, 1 mg

Q5158

Inj, denosumab-bnht, 1 mg

Q5162

Inj, denosumab-nxxp, 1 mg

Q5157

Inj, denosumab-bmwo, 1 mg

Q5164

Ustekinumab-hmny, 1 mg

Q5156

Inj, tocilizumab-anoh, 1 mg

Q5155

Inj, aflibercept-jbvf, 1 mg

Sources

Reference information only. Not billing advice. Verify against the payer before you file.